Glutamine enters the cells mainly through the alanine, serine, cysteine, and glutamate transporter (ASCT2), targeted by the oncosuppressor miR-137, which inversely correlates with ASCT2 in glioblastoma, CRC, PDAC and PC. The gene discussed is SLC1A5; the disease is colorectal carcinoma.